Logo
x

Search category

Subscribe Now

European Commission Approval

Sanofi's Dupixent (dupilumab) Receives EC's Approval for Children with Severe Atopic Dermatitis

Sanofi's Dupixent (dupilumab) Receives EC's Approval for Children with Severe Atopic Dermatitis

  • December 1, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.